ALMEE Trademark

Trademark Overview


On Monday, October 24, 2022, a trademark application was filed for ALMEE with the United States Patent and Trademark Office. The USPTO has given the ALMEE trademark a serial number of 97644561. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by Vicore Pharma AB. The ALMEE trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing of on-line training and continuing education in the nature of virtual lectures in the field of medicine, health and wellness for users in the medical fields with the aid of software; Educational services, namely, providing continuing professional education courses, webinars, seminars, and workshops in the field of medicine, health and wellness for patients suffering from depression and anxiety related to Pulmonary Fibrosis and for medical personnel specialized on the treatment of depression and anxiety

Downloadable computer software with medical information and content for facilitating the provision of medical advice in the field of depression and anxiety related to Pulmonary Fibrosis; downloadable computer software programs for the administration of scientific content in the nature of analysis of medical data; downloadable computer programs, in particular interactive downloadable medical software for treating patients suffering from depression and anxiety related to Pulmonary Fibrosis and for supporting medical personnel for the purpose of treating depression and anxiety; downloadable computer software program which is designed to assist patients in reducing and coping with the symptoms of depression and anxiety related to Pulmonary Fibrosis as well as in improving their wellbeing and social occupational functioning and to support health care professionals involved in the treatment of patients with depression and anxiety related to Pulmonary Fibrosis by facilitating the provision of...

Therapeutic services, namely, medical counselling, psychological counselling, medical advice and medical information provided to patients with, and care givers treating, depression and anxiety related to Pulmonary Fibrosis; Providing medical information, namely, computer-based interactive medical support services in the nature of providing online medical advice for assisting with treatment of patients suffering from depression and anxiety related to Pulmonary Fibrosis and their families

Providing a website featuring digital therapeutic technology that enables users to access resources for treating depression and anxiety related to Pulmonary Fibrosis; providing an online digital therapeutic platform in the nature of providing on-line non-downloadable software for providing behavioural health services, namely, coaching, counselling, advice in the field of depression and anxiety related to Pulmonary Fibrosis; conducting medical and scientific and technological research in the field of depression and anxiety related to Pulmonary Fibrosis; Scientific and technological services, namely, conducting technological research and design of digital therapeutics for computer-based interactive and online psychological intervention and counselling in the field of depression and anxiety related to Pulmonary Fibrosis; providing temporary use of non-downloadable computer programs for administration of digital therapeutic and medical content in the field of depression and anxiety related...
almee

General Information


Serial Number97644561
Word MarkALMEE
Filing DateMonday, October 24, 2022
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7395516
Registration DateTuesday, May 28, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesProviding of on-line training and continuing education in the nature of virtual lectures in the field of medicine, health and wellness for users in the medical fields with the aid of software; Educational services, namely, providing continuing professional education courses, webinars, seminars, and workshops in the field of medicine, health and wellness for patients suffering from depression and anxiety related to Pulmonary Fibrosis and for medical personnel specialized on the treatment of depression and anxiety
Description of MarkThe mark consists of of a green outline of overlapping, rounded geometric figures all connected at the bottom above "ALMEE" in stylized green font. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
Goods and ServicesDownloadable computer software with medical information and content for facilitating the provision of medical advice in the field of depression and anxiety related to Pulmonary Fibrosis; downloadable computer software programs for the administration of scientific content in the nature of analysis of medical data; downloadable computer programs, in particular interactive downloadable medical software for treating patients suffering from depression and anxiety related to Pulmonary Fibrosis and for supporting medical personnel for the purpose of treating depression and anxiety; downloadable computer software program which is designed to assist patients in reducing and coping with the symptoms of depression and anxiety related to Pulmonary Fibrosis as well as in improving their wellbeing and social occupational functioning and to support health care professionals involved in the treatment of patients with depression and anxiety related to Pulmonary Fibrosis by facilitating the provision of medical advice; downloadable computer application software for websites, mobile telephones and mobile devices, namely, software for treating patients suffering from depression and anxiety related to Pulmonary Fibrosis; downloadable printable educational materials featuring therapeutic medical and counselling content, in the nature of information, forms, instructions, charts, studies, data and related coaching and advice in the field of depression and anxiety related to Pulmonary Fibrosis, treatment of depression and anxiety related to Pulmonary Fibrosis, and related health and wellness; downloadable electronic publications, namely, newsletters and articles for use by medical professionals and patients in the field of depression and anxiety related to Pulmonary Fibrosis
Indication of Colors claimedThe color(s) green is/are claimed as a feature of the mark.
Goods and ServicesTherapeutic services, namely, medical counselling, psychological counselling, medical advice and medical information provided to patients with, and care givers treating, depression and anxiety related to Pulmonary Fibrosis; Providing medical information, namely, computer-based interactive medical support services in the nature of providing online medical advice for assisting with treatment of patients suffering from depression and anxiety related to Pulmonary Fibrosis and their families
Goods and ServicesProviding a website featuring digital therapeutic technology that enables users to access resources for treating depression and anxiety related to Pulmonary Fibrosis; providing an online digital therapeutic platform in the nature of providing on-line non-downloadable software for providing behavioural health services, namely, coaching, counselling, advice in the field of depression and anxiety related to Pulmonary Fibrosis; conducting medical and scientific and technological research in the field of depression and anxiety related to Pulmonary Fibrosis; Scientific and technological services, namely, conducting technological research and design of digital therapeutics for computer-based interactive and online psychological intervention and counselling in the field of depression and anxiety related to Pulmonary Fibrosis; providing temporary use of non-downloadable computer programs for administration of digital therapeutic and medical content in the field of depression and anxiety related to Pulmonary Fibrosis and the treatment of depression and anxiety related to Pulmonary Fibrosis

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, November 7, 2022
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, November 7, 2022
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 7, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 7, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVicore Pharma AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGothenburg SE-41105
SE

Party NameVicore Pharma AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGothenburg SE-41105
SE

Party NameVicore Pharma AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGothenburg SE-41105
SE

Trademark Events


Event DateEvent Description
Thursday, October 27, 2022NEW APPLICATION ENTERED
Monday, November 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 8, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, January 19, 2023ASSIGNED TO EXAMINER
Thursday, January 19, 2023NON-FINAL ACTION WRITTEN
Thursday, January 19, 2023NON-FINAL ACTION E-MAILED
Thursday, January 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 1, 2023SUSPENSION LETTER WRITTEN
Wednesday, February 1, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, February 1, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 28, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, August 18, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, September 7, 2023NON-FINAL ACTION WRITTEN
Thursday, September 7, 2023NON-FINAL ACTION E-MAILED
Thursday, September 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 14, 2023NON-FINAL ACTION WRITTEN
Thursday, September 14, 2023NON-FINAL ACTION E-MAILED
Thursday, September 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 17, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 19, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, February 1, 2024ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED